| Identification | Back Directory | [Name]
Lanifibranor | [CAS]
927961-18-0 | [Synonyms]
CPD1537
IVA-337
Lanifibranor
IVA337;IVA-337
Lanifibranor (IVA337)
LANIFIBRANOR |PACK AS 1GX1 +11GX1
1H-Indole-2-butanoic acid, 1-(6-benzothiazolylsulfonyl)-5-chloro-
5-chloro-1-[(6-benzothiazolyl)sulfonyl]-1H-indole-2-butanoic acid
4-(1-(1,3-Benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl)butanoic Acid
4-(1-(benzo[d]thiazol-6-ylsulfonyl)-5-chloro-1H-indol-2-yl)butanoic acid | [EINECS(EC#)]
691-126-0 | [Molecular Formula]
C19H15ClN2O4S2 | [MDL Number]
MFCD31619253 | [MOL File]
927961-18-0.mol | [Molecular Weight]
434.92 |
| Chemical Properties | Back Directory | [Boiling point ]
690.9±65.0 °C(Predicted) | [density ]
1.56±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMF:50.0(Max Conc. mg/mL);114.97(Max Conc. mM)
DMSO:79.0(Max Conc. mg/mL);181.65(Max Conc. mM)
DMSO:PBS (pH 7.2) (1:4):0.2(Max Conc. mg/mL);0.46(Max Conc. mM)
Ethanol:0.2(Max Conc. mg/mL);0.46(Max Conc. mM) | [form ]
A crystalline solid | [pka]
4.69±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
Lanifibranor, a new antifibrotic clinical candidate, acting as a pan peroxisome proliferator-activated receptor (PPAR) agonist. | [storage]
Store at -20°C |
|
|